Small Stocks, Big Money

RedChip Companies

RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. Founded in 1992, and headquartered in Orlando, Florida, with affiliates in New York and Pittsburgh, RedChip has helped hundreds of companies achieve their capital markets goals. RedChip has been ranked by Inc. magazine as one of the fastest growing privately held investor relations firms in the U.S. RedChip represents 70+ emerging growth companies in a variety of industries including Biotechnology and BioPharma, Business Services, Consumer Goods, High Tech, Mining and Minerals.

  1. Oct 27

    CEO Sharon Carmel on Beamr (Nasdaq: BMR) 40% Data Reduction Validated by NVIDIA

    CEO Sharon Carmel explains how Beamr (Nasdaq: BMR) is applying its Emmy-winning video optimization technology to autonomous vehicles and physical AI.Beamr reduces video data by up to 50% on top of existing compression technologies, and its customers include Netflix and Paramount. AI is opening a far larger market for Beamr’s technology. Carmel notes that a streaming giant may need 100,000 hours of video to build its catalog, while a self-driving car may need 20 million hours, 200 times more data. That volume clogs storage and networks. Conventional compression is built for human viewers and can degrade what machine vision models need to see, such as the edges of objects. Beamr’s ML-Safe approach is designed to preserve that information so models get the same results from compressed video.NVIDIA AV Infrastructure team tested Beamr’s technology on its own data and validated about a 40% reduction in data with no model degradation.Carmel also discusses an unexpected research finding: training a model on Beamr-optimized video reduced the model’s error. If the result continues to hold, Beamr could become part of the AI training process itself. As he puts it, the technology is developed and now entering its commercial phase.👉 Beamr is a client of RedChip. To learn more about BMR and to read our full disclosure, visit: https://www.redchip.com/stocks/bmr#BMR #Beamr #VideoCompression #AutonomousVehicles #PhysicalAI #ArtificialIntelligence #NVIDIA #ADAS #TechStocks #Nasdaq #SmallCapStocks #StockInterviews #InvestorEducation

  2. Oct 20

    Hoya Capital CIO David Auerbach on REITs, Real Estate & Building Portfolio Income

    David Auerbach, Chief Investment Officer of Hoya Capital, joins RedChip to discuss the role of REITs and real estate securities in building sustainable portfolio income, along with the opportunities and challenges shaping today’s real estate investment landscape.Hoya Capital Real Estate is a research-focused investment advisor specializing in REITs, real estate securities, and income-oriented investment strategies. The firm provides research and market analysis covering the universe of U.S.-listed real estate companies, with a focus on helping investors better understand income-producing real estate and dividend-focused investment opportunities. Hoya CapitalAuerbach brings nearly 25 years of experience in the REIT industry. Before joining Hoya Capital as Chief Investment Officer, he served as Managing Director of Armada ETF Advisors and spent 11 years at Green Street Advisors as Vice President of Institutional Trading, working with institutional investors, hedge funds, pension funds, and other market participants. He is also the publisher of The Daily REITBeat Newsletter, which covers developments across the publicly traded REIT sector. Hoya CapitalHoya Capital’s broader platform combines investment research, market commentary, and real estate indexes. The firm is the index provider behind the Hoya Capital High Dividend Yield Index (RIET) and Hoya Capital Housing Index (HOMZ), designed to provide exposure to high-dividend real estate securities and companies connected to the U.S. housing industry. Hoya CapitalIn this interview, discover Hoya Capital’s approach to real estate investing and why REITs, dividends, diversification, and long-term income generation remain important considerations for investors navigating changing market conditions.👉 Learn more about Hoya Capital: hoyacapital.com#HoyaCapital #DavidAuerbach #REITs #RealEstate #RealEstateInvesting #DividendInvesting #IncomeInvesting #Investing #ETFs #PortfolioIncome #InvestorEducation #RedChip #StockInterviews

  3. Oct 13

    Horizon Aircraft's (Nasdaq: HOVR) CEO Brandon Robinson on Path to 2030 Deliveries

    Horizon Aircraft (Nasdaq: HOVR) Co-Founder and CEO Brandon Robinson outlines the path to commercialization for the Cavorite X7. It's a hybrid-electric VTOL aircraft that takes off and lands like a helicopter and flies like a conventional airplane for about 98% of its mission.Much of the eVTOL industry is focused on shorter, high-frequency all-electric routes. Horizon is targeting faster, longer-range, all-weather routes of roughly 300 to 500 miles between cities. The Cavorite X7 combines Horizon's patented fan-in-wing technology with an onboard engine and generator, so it carries hundreds of pounds of batteries instead of thousands. Robinson describes its fuel source as 20 to 30 times more energy-dense than typical battery systems. He positions the aircraft as complementary to all-electric platforms from Joby, Archer and Beta, built by integrating technologies that are available today instead of relying on future breakthroughs.The Cavorite X7 targets ~250 mph speeds, a ~500-mile range and a useful load of up to 1,500 lbs, with operating costs of ~$0.97 per seat mile versus ~$4–$6 for comparable helicopters. Horizon has already demonstrated vertical takeoff, transition and forward flight with a large-scale prototype. It was one of five companies selected from ~250 applicants for the U.S. Air Force AFWERX High-Speed VTOL program.Horizon expects to roll out its full-scale prototype within six months for ground testing, followed by flight testing over the next 12 to 18 months. The company is pursuing certification through Transport Canada Civil Aviation, with potential FAA validation through bilateral agreements. It's building low-volume production capacity, with aircraft deliveries targeted for 2030.👉 Horizon Aircraft is a client of RedChip. To learn more about HOVR and to read our full disclosure, visit: https://www.redchip.com/stocks/hovr#HOVR #HorizonAircraft #CavoriteX7 #eVTOL #VTOL #AdvancedAirMobility #HybridElectric #AerospaceStocks #AviationStocks #DefenseStocks #Nasdaq #SmallCapStocks #InvestorEducation #StockInterviews

  4. Oct 6

    Bimergen Energy (NYSE American: BESS): Powering the Future of U.S. Battery Energy Storage

    Bimergen Energy Corporation (NYSE American: BESS) is a U.S. energy infrastructure developer, asset owner, and operator focused on utility-scale battery energy storage systems (BESS). The company has assembled a diversified pipeline of approximately 2.0 GW across major U.S. power markets, including ERCOT, PJM, WECC, and MISO. Bimergen is advancing its portfolio from development toward construction and commercialization through a capital-efficient strategy that combines institutional partnerships, project monetization, milestone payments, and retained ownership interests. Its portfolio includes the 100 MW / 400 MWh Redbird project near Houston and a growing portfolio of distributed battery storage assets. In Q2 2026, Bimergen reported $7.9 million in revenue, $3.9 million in Adjusted EBITDA, and $1.6 million in net income. The company also received $11 million in cash related to Q2 revenues and retained a 7.5% ownership interest in three monetized ERCOT projects totaling 480 MWh. Battery energy storage systems can help strengthen grid reliability by storing electricity during lower-cost periods and dispatching it when demand and prices rise. Bimergen is positioning its project pipeline to capitalize on growing demand for energy storage driven by renewable energy integration, electrification, and increasing power requirements across the U.S. Watch to learn more about Bimergen Energy’s strategy, 2.0 GW project pipeline, battery storage portfolio, and plans to participate in the continued buildout of U.S. energy infrastructure.NYSE American: BESSLearn more about Bimergen Energy (BESS): redchip.com/stocks/BESS#BESS #BimergenEnergy #BatteryStorage #EnergyStorage #CleanEnergy #EnergyInfrastructure #ERCOT #RenewableEnergy #GridStorage #NYSEAmerican #Investing #RedChip

  5. Sep 29

    Gold and Antinmony, Full Production by 2027 | Chris Gerteisen on Nova Minerals (NYSE-A: NVA)

    CEO Christopher Gertyson joins RedChip to detail how Nova Minerals (Nasdaq: NVA) is advancing a rare dual-commodity story at its flagship Estelle Project in Alaska — pairing near-term U.S. critical mineral production with one of the largest undeveloped gold resources in the world.Estelle is a district-scale project spanning 514 km² in the Tintina Gold Belt, hosting a 35 km mineralized corridor with more than 20 identified gold and antimony prospects. Nova is building a vertically integrated antimony business — mining and refining domestically in Alaska — to establish what Gertyson describes as the first fully domestic antimony supply chain in decades, with a secured refinery site at Port MacKenzie. Recent executive orders prioritizing Alaska's mineral resources and restricting antimony imports from foreign adversaries have sharpened the strategic case for Nova's "big three" critical minerals focus: antimony, tungsten, and gallium.The company's phase one antimony program is fully funded by a $43.4 million Department of War award under the Defense Production Act, targeting production of military-grade antimony trisulfide — used in small and medium caliber munitions primers — by 2026/27. On the gold side, Estelle hosts a 5.2 million ounce pit-constrained (S-K 1300) resource across the Correll and RPM deposits, including intercepts of 132 meters at 10.1 g/t gold (RPM-005) and 117 meters at 11.1 g/t gold (RPM-015). Nova holds an 85% ownership stake in the project and reports a market cap of roughly $481 million, with remaining cash reserves directed entirely toward advancing the gold asset alongside the fully-funded antimony work.Looking ahead, Gertyson outlined a feasibility study now underway, active season drilling at Corbal and RPM, and a goal of reaching a construction-ready gold project by 2028/2029. A successful phase one antimony ramp could unlock additional Department of War funding for phase two, scaling into refined products like antimony trioxide for broader U.S. industrial and defense markets. Gertyson frames the story simply: Nova is transitioning from explorer to producer, minimizing dilution while advancing what he calls one of the largest undeveloped gold projects in the world — critical minerals and gold, in America, for America.👉 Nova Minerals is a client of RedChip. To learn more about NVA and to read our full disclosure, visit: https://www.NVAinfo.com#NVA #NovaMinerals #Antimony #Gold #CriticalMinerals #Alaska #EstelleProject #DefenseStocks #MiningStocks #SmallCapStocks #MicroCapStocks #Nasdaq #InvestorEducation #StockInterviews

  6. Sep 15

    One Solution, Five Disease Pathways: CEO Pete O'Heeron on Fibrobiologic's (Nasdaq: FBLG) Fribroblast

    CEO Pete O'Heeron joins RedChip to explain why FibroBiologics (Nasdaq: FBLG) believes fibroblasts, not stem cells, represent the next major platform in regenerative medicine.FibroBiologics is a clinical-stage biotech built around a simple but underappreciated fact: fibroblasts, the cell type behind Dr. Shinya Yamanaka's Nobel Prize-winning discovery of induced pluripotent stem cells, appear to be more potent and more immune-modulating than the stem cells they helped create. They also outnumber stem cells roughly 5,000 to 1 in the human body. Rather than building around a single drug candidate, as many biotech companies do, FibroBiologics has used that abundance to construct a multi-program platform spanning wound care, orthopedics, autoimmune disease, oncology, and thymus regeneration — an approach O'Heeron says has produced clinical-stage success across every therapeutic pathway the company has pursued.The company's furthest-along program targets diabetic foot ulcers, where O'Heeron says fibroblasts do what they do best: heal wounds. It's a 12-week trial designed to validate in the clinic what has been shown in animal studies, healing time cut in half compared to a leading wound-care product from Smith & Nephew. That program sits alongside a broader pipeline spanning autoimmune disease, orthopedics, oncology, and thymus regeneration. The company says it has seen clinical success on every therapeutic pathway it has pursued so far. Its intellectual property position underpins that breadth: more than 250 patents issued and pending, covering therapeutic use of fibroblasts.👉 FibroBiologics is a client of RedChip. To learn more about FBLG and to read our full disclosure, visit: https://www.FBLGinfo.com#FBLG #FibroBiologics #Fibroblasts #CellTherapy #RegenerativeMedicine #StemCellAlternative #DiabeticFootUlcers #MultipleSclerosis #WoundCare #Biotech #SmallCapStocks #Nasdaq #InvestorEducation #StockInterviews

Ratings & Reviews

3
out of 5
2 Ratings

About

RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. Founded in 1992, and headquartered in Orlando, Florida, with affiliates in New York and Pittsburgh, RedChip has helped hundreds of companies achieve their capital markets goals. RedChip has been ranked by Inc. magazine as one of the fastest growing privately held investor relations firms in the U.S. RedChip represents 70+ emerging growth companies in a variety of industries including Biotechnology and BioPharma, Business Services, Consumer Goods, High Tech, Mining and Minerals.